Strong revenue performance, rising institutional interest, and a positive outlook position the animal health leader for continued momentum
New York, United States, 6 April 2026...
Strong revenue performance, rising institutional interest, and a positive outlook position the animal health leader for continued momentum
New York, United States, 6 April 2026...
Strong sales growth contrasts with widening losses, keeping margins, debt, and execution under the spotlight
New York, United States, 27 February 2026 - Elanco Animal...
Stronger earnings, steady revenue gains, and a discounted valuation fuel renewed confidence in a once-struggling animal health leader.
Indianapolis, Indiana, 4 December 2025 – Elanco...
